XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Public offering
Common stock
At-the-market sales
Common stock
Additional Paid in Capital.
Public offering
Additional Paid in Capital.
At-the-market sales
Additional Paid in Capital.
Accumulated Other Comprehensive Income
Accumulated Deficit
Public offering
At-the-market sales
Total
Balance at Dec. 31, 2019     $ 7     $ 306,108   $ (260,370)     $ 45,745
Balance (in shares) at Dec. 31, 2019     69,810,305                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           621         621
Issuance of common stock $ 2     $ 48,433         $ 48,435    
Issuance of common stock (in shares) 17,250,000                    
Issuance of common stock upon exercise of options           119         119
Issuance of common stock upon exercise of options (in shares)     152,907                
Warrants issued in connection with long-term debt           3,570         3,570
Net loss               (7,883)     (7,883)
Balance at Mar. 31, 2020     $ 9     358,851   (268,253)     90,607
Balance (in shares) at Mar. 31, 2020     87,213,212                
Balance at Dec. 31, 2019     $ 7     306,108   (260,370)     45,745
Balance (in shares) at Dec. 31, 2019     69,810,305                
Increase (decrease) in stockholders' equity                      
Unrealized net gain on marketable securities                     11
Net loss                     (34,233)
Balance at Sep. 30, 2020     $ 9     360,713 $ 11 (294,603)     66,130
Balance (in shares) at Sep. 30, 2020     87,434,604                
Balance at Mar. 31, 2020     $ 9     358,851   (268,253)     90,607
Balance (in shares) at Mar. 31, 2020     87,213,212                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           839         839
Issuance of common stock upon exercise of options           166         166
Issuance of common stock upon exercise of options (in shares)     84,393                
Unrealized net gain on marketable securities             10       10
Net loss               (10,826)     (10,826)
Balance at Jun. 30, 2020     $ 9     359,856 10 (279,079)     80,796
Balance (in shares) at Jun. 30, 2020     87,297,605                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           647         647
Issuance of common stock upon exercise of options           210         210
Issuance of common stock upon exercise of options (in shares)     136,999                
Unrealized net gain on marketable securities             1       1
Net loss               (15,524)     (15,524)
Balance at Sep. 30, 2020     $ 9     360,713 11 (294,603)     66,130
Balance (in shares) at Sep. 30, 2020     87,434,604                
Balance at Dec. 31, 2020     $ 9     361,539 3 (312,223)     49,328
Balance (in shares) at Dec. 31, 2020     87,563,753                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           742         742
Issuance of common stock         $ 960         $ 960  
Issuance of common stock (in shares)   520,937                  
Issuance of common stock upon exercise of options           75         75
Issuance of common stock upon exercise of options (in shares)     126,400                
Vesting of RSUs (in shares)     52,651                
Warrants issued in connection with long-term debt           1,080         1,080
Unrealized net gain on marketable securities             (3)       (3)
Net loss               (17,128)     (17,128)
Balance at Mar. 31, 2021     $ 9     364,396   (329,351)     35,054
Balance (in shares) at Mar. 31, 2021     88,263,741                
Balance at Dec. 31, 2020     $ 9     361,539 $ 3 (312,223)     49,328
Balance (in shares) at Dec. 31, 2020     87,563,753                
Increase (decrease) in stockholders' equity                      
Issuance of common stock (in shares)   6,915,151                  
Unrealized net gain on marketable securities                     (3)
Net loss                     (51,537)
Balance at Sep. 30, 2021     $ 9     374,431   (363,760)     10,680
Balance (in shares) at Sep. 30, 2021     94,729,385                
Balance at Mar. 31, 2021     $ 9     364,396   (329,351)     35,054
Balance (in shares) at Mar. 31, 2021     88,263,741                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           843         843
Issuance of common stock         6,349         6,349  
Issuance of common stock (in shares)   4,593,034                  
Vesting of RSUs (in shares)     71,430                
Net loss               (17,637)     (17,637)
Balance at Jun. 30, 2021     $ 9     371,588   (346,988)     24,609
Balance (in shares) at Jun. 30, 2021     92,928,205                
Increase (decrease) in stockholders' equity                      
Share-based compensation - stock options and RSUs           887         887
Issuance of common stock         $ 1,956         $ 1,956  
Issuance of common stock (in shares)   1,801,180                  
Net loss               (16,772)     (16,772)
Balance at Sep. 30, 2021     $ 9     $ 374,431   $ (363,760)     $ 10,680
Balance (in shares) at Sep. 30, 2021     94,729,385